Literature DB >> 30455198

Mycobacterium tuberculosis Requires Regulation of ESX-5 Secretion for Virulence in Irgm1-Deficient Mice.

Sarah R Elliott1, Dylan W White1, Anna D Tischler2.   

Abstract

The Mycobacterium tuberculosis type VII secretion system ESX-5, which has been implicated in virulence, is activated at the transcriptional level by the phosphate starvation-responsive Pst/SenX3-RegX3 signal transduction system. Deletion of pstA1, which encodes a Pst phosphate transporter component, causes constitutive activation of the response regulator RegX3, hypersecretion of ESX-5 substrates and attenuation in the mouse infection model. We hypothesized that constitutive activation of ESX-5 secretion causes attenuation of the ΔpstA1 mutant. To test this, we uncoupled ESX-5 from regulation by RegX3. Using electrophoretic mobility shift assays, we defined a RegX3 binding site in the esx-5 locus. Deletion or mutation of the RegX3 binding site reversed hypersecretion of the ESX-5 substrate EsxN by the ΔpstA1 mutant and abrogated induction of EsxN secretion in response to phosphate limitation by wild-type M. tuberculosis The esx-5 RegX3 binding site deletion (ΔBS) also suppressed attenuation of the ΔpstA1 mutant in Irgm1-/- mice. These data suggest that constitutive ESX-5 secretion sensitizes M. tuberculosis to an immune response that still occurs in Irgm1-/- mice. However, the ΔpstA1 ΔBS mutant remained attenuated in both NOS2-/- and C57BL/6 mice, suggesting that factors other than ESX-5 secretion also contribute to attenuation of the ΔpstA1 mutant. In addition, a ΔpstA1 ΔesxN mutant lacking the hypersecreted ESX-5 substrate EsxN remained attenuated in Irgm1-/- mice, suggesting that ESX-5 substrates other than EsxN cause increased susceptibility to host immunity. Our data indicate that while M. tuberculosis requires ESX-5 for virulence, it tightly controls secretion of ESX-5 substrates to avoid elimination by host immune responses.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  ESX secretion; Mycobacterium tuberculosiszzm321990; Pst system; SenX3-RegX3; gene regulation; phosphate; two-component regulatory systems; type VII secretion

Mesh:

Substances:

Year:  2019        PMID: 30455198      PMCID: PMC6346127          DOI: 10.1128/IAI.00660-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity.

Authors:  S Fishbein; N van Wyk; R M Warren; S L Sampson
Journal:  Mol Microbiol       Date:  2015-03-30       Impact factor: 3.501

2.  The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death.

Authors:  Carl G Feng; Lixin Zheng; Dragana Jankovic; André Báfica; Jennifer L Cannons; Wendy T Watford; Damien Chaussabel; Sara Hieny; Patricia Caspar; Pamela L Schwartzberg; Michael J Lenardo; Alan Sher
Journal:  Nat Immunol       Date:  2008-09-21       Impact factor: 25.606

3.  MprAB regulates the espA operon in Mycobacterium tuberculosis and modulates ESX-1 function and host cytokine response.

Authors:  Xiuhua Pang; Buka Samten; Guangxiang Cao; Xisheng Wang; Amy R Tvinnereim; Xiu-Lan Chen; Susan T Howard
Journal:  J Bacteriol       Date:  2012-10-26       Impact factor: 3.490

4.  Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages.

Authors:  Paolo S Manzanillo; Michael U Shiloh; Daniel A Portnoy; Jeffery S Cox
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

5.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Precise large deletions by the PCR-based overlap extension method.

Authors:  S D Senanayake; D A Brian
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

7.  Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.

Authors:  JoAnn M Tufariello; Jessica R Chapman; Christopher A Kerantzas; Ka-Wing Wong; Catherine Vilchèze; Christopher M Jones; Laura E Cole; Emir Tinaztepe; Victor Thompson; David Fenyö; Michael Niederweis; Beatrix Ueberheide; Jennifer A Philips; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

8.  Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential.

Authors:  Fadel Sayes; Lin Sun; Mariagrazia Di Luca; Roxane Simeone; Nathalie Degaiffier; Laurence Fiette; Semih Esin; Roland Brosch; Daria Bottai; Claude Leclerc; Laleh Majlessi
Journal:  Cell Host Microbe       Date:  2012-04-19       Impact factor: 21.023

9.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  The ESX-5 associated eccB-EccC locus is essential for Mycobacterium tuberculosis viability.

Authors:  Mariagrazia Di Luca; Daria Bottai; Giovanna Batoni; Mickael Orgeur; Anna Aulicino; Claudio Counoupas; Mario Campa; Roland Brosch; Semih Esin
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more
  2 in total

Review 1.  Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation.

Authors:  Trisha Parbhoo; Jacoba M Mouton; Samantha L Sampson
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

Review 2.  Two-component sensor histidine kinases of Mycobacterium tuberculosis: Beacons for niche navigation.

Authors:  Miljan Stupar; Juanelle Furness; Christopher J De Voss; Lendl Tan; Nicholas P West
Journal:  Mol Microbiol       Date:  2022-04-11       Impact factor: 3.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.